Voltage-dependent block of normal and mutant muscle sodium channels by 4-Chloro-m-Cresol

G Haeseler1, M Leuwer, J Kavan

  • 1Department of Anaesthesiology, Hannover Medical School, D-30623 Hannover, Germany.

Insights

4-Chloro-m-Cresol (4-CmC) effectively blocks muscle sodium channels, similar to lidocaine. It restores normal function in certain genetic muscle channel disorders by correcting impaired inactivation and recovery.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • Muscle sodium channels are crucial for nerve impulse transmission.
  • Mutations in sodium channels cause genetic muscle disorders like Paramyotonia Congenita and Hyperkalemic Periodic Paralysis.
  • Understanding how compounds affect sodium channel function is key to developing treatments.

Purpose of the Study:

  • To investigate the effects of 4-Chloro-m-Cresol (4-CmC) on wild-type and mutant human muscle sodium channels.
  • To determine the concentration-dependent block and effects on channel inactivation and recovery.
  • To compare the efficacy of 4-CmC with known sodium channel blockers like lidocaine.

Main Methods:

  • Heterologous expression of wild-type (WT) and mutant (R1448H, M1360V) human muscle sodium channel alpha-subunits.
  • Electrophysiological recordings to assess sodium channel block, inactivation, and recovery.
  • Concentration-response analysis to determine EC50 values.
  • Application of inactivating prepulses to study state-dependent block.

Main Results:

  • 4-CmC demonstrated concentration-dependent block of rested sodium channels (EC50: 0.40-0.49 mM).
  • Inactivation significantly enhanced 4-CmC block, especially at depolarized potentials.
  • 4-CmC accelerated current decay and prolonged recovery from inactivation, restoring mutant channel function towards WT levels.
  • No frequency-dependent block was observed with 4-CmC.

Conclusions:

  • 4-Chloro-m-Cresol (4-CmC) is a potent blocker of human muscle sodium channels, comparable to lidocaine.
  • 4-CmC effectively corrects impaired inactivation and abnormal recovery in specific sodium channel mutants.
  • These findings suggest potential therapeutic applications for 4-CmC in treating certain myopathies.

Related Concept Videos

Patch Clamp01:18

Patch Clamp

Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...